Title | Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR. |
Publication Type | Journal Article |
Year of Publication | 2003 |
Authors | Bais C, Van Geelen A, Eroles P, Mutlu A, Chiozzini C, Dias S, Silverstein RL, Rafii S, Mesri EA |
Journal | Cancer Cell |
Volume | 3 |
Issue | 2 |
Pagination | 131-43 |
Date Published | 2003 Feb |
ISSN | 1535-6108 |
Keywords | Apoptosis, Cell Transformation, Neoplastic, Cells, Cultured, Endothelial Growth Factors, Endothelium, Vascular, Herpesvirus 8, Human, Humans, Intercellular Signaling Peptides and Proteins, Lymphokines, Phosphatidylinositol 3-Kinases, Phosphorylation, Protein Serine-Threonine Kinases, Proto-Oncogene Proteins, Proto-Oncogene Proteins c-akt, Receptors, Chemokine, Retroviridae, Sarcoma, Kaposi, Signal Transduction, Telomerase, Telomere, Umbilical Veins, Vascular Endothelial Growth Factor A, Vascular Endothelial Growth Factor Receptor-2, Vascular Endothelial Growth Factors, Viral Proteins |
Abstract | The G protein-coupled receptor oncogene (vGPCR) of the Kaposi's sarcoma (KS) associated herpesvirus (KSHV), an oncovirus implicated in angioproliferative neoplasms, induces angiogenesis by VEGF secretion. Accordingly, we found that expression of vGPCR in human umbilical vein endothelial cells (HUVEC) leads to immortalization with constitutive VEGF receptor-2/ KDR expression and activation. vGPCR immortalization was associated with anti-senescence mediated by alternative lengthening of telomeres and an anti-apoptotic response mediated by vGPCR constitutive signaling and KDR autocrine signaling leading to activation of the PI3K/AKT pathway. In the presence of the KS growth factor VEGF, this mechanism can sustain suppression of signaling by the immortalizing gene. We conclude that vGPCR can cause an oncogenic immortalizing event and recapitulate aspects of the KS angiogenic phenotype in human endothelial cells, pointing to this gene as a pathogenic determinant of KSHV. |
DOI | 10.1016/s1535-6108(03)00024-2 |
Alternate Journal | Cancer Cell |
PubMed ID | 12620408 |
Grant List | AI 391920 / AI / NIAID NIH HHS / United States R01 CA 91574 / CA / NCI NIH HHS / United States |